新闻中心

News Center

The company held the product launch of Oran

Release Time

2022-06-22 11:09

On December 6, 2013, the company held a product launch conference of Oran in the exhibition hall of the Westin Hotel in Guangzhou Canton Fair. The guests who participated in the conference were Mr. Scheis, the chief representative of India Dr. Reddy Laboratory Co., Ltd. in China. Dr. Amit, the medical director, Mr. Peng Huiming, the director of government affairs, and Mr. Liu Yu, the executive director of the Pharmaceutical Research and Development Center of Renmin University of China. The conference is divided into four main parts:

1. Launching Ceremony of Oran's China Tour;

2. Mr. Qin Cheng, Chairman of Foncoo Pharmaceutical, delivered a speech;

3. Mr. Schiess, the chief representative of Dr. Reddy in China, introduced Dr. Reddy and its development strategy in China;

4. Dr. Amit, the global medical director of Dr. Ruidi, introduced Oranzhi. The conference attracted more than 70 professional agents in the field of psychiatry from all over the country. All of them witnessed the listing of Oranzhi in China with a good vision, and looked forward to reaching the cooperation of Oranzhi with the company.

The atmosphere of the tea break after the meeting was very warm. Agents from all over the world took this opportunity to come forward to discuss cooperation opportunities with the company's chairman and marketing director, and expressed their confidence in the broad market prospects of Oran's listing!

 

 

 

 

 

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称